Iol Chemicals Pharmaceuticals Ltd vs Kabra Drugs Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of IOL Chemicals & Pharmaceuticals Ltd is ₹ 94.66 as of 05 May 15:30 . The P/E Ratio of IOL Chemicals & Pharmaceuticals Ltd changed from 12.4 on March 2022 to 17.8 on March 2025 . This represents a CAGR of 9.46% over 4 yearsThe P/E Ratio of Kabra Drugs Ltd changed from 0 on March 2022 to 0 on March 2025 . This represents a CAGR of 0.0% over 4 years The Market Cap of IOL Chemicals & Pharmaceuticals Ltd changed from ₹ 2077 crore on March 2022 to ₹ 1796 crore on March 2025 . This represents a CAGR of -3.56% over 4 yearsThe Market Cap of Kabra Drugs Ltd changed from ₹ 0 crore on March 2022 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 4 years The revenue of IOL Chemicals & Pharmaceuticals Ltd for the Dec '25 is ₹ 585.68 crore as compare to the Sep '25 revenue of ₹ 574.41 crore. This represent the growth of 1.96% The revenue of Kabra Drugs Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of IOL Chemicals & Pharmaceuticals Ltd for the Dec '25 is ₹ 51.36 crore as compare to the Sep '25 ebitda of ₹ 63.96 crore. This represent the decline of -19.7% The ebitda of Kabra Drugs Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of IOL Chemicals & Pharmaceuticals Ltd changed from ₹ 29.97 crore to ₹ 20.58 crore over 7 quarters. This represents a CAGR of -19.33% The net profit of Kabra Drugs Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of IOL Chemicals & Pharmaceuticals Ltd changed from 7.92 % on March 2021 to 23.25 % on March 2025 . This represents a CAGR of 24.03% over 5 yearsThe Dividend Payout of Kabra Drugs Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About IOL Chemicals & Pharmaceuticals Ltd

IOL Chemicals and Pharmaceuticals Limited, incorporated in September, 1986 is a renowned company in the Active Pharmaceutical Ingredient (API) and specialty chemicals sectors.
Its extensive expertise in both API and specialty chemicals strengthens the business model and opens doors to diversified growth opportunities. Within the API segment, IOL develops and supplies a wide range of essential products utilized by pharmaceutical companies worldwide for the production of key medicines.
It serves as a global supplier of various APIs, including Ibuprofen, Metformin, Clopidogrel, Lamotrigine, Pantoprazole, and Fenofibrate, alongside other APIs, and maintains a significant presence in all major therapeutic categories. In the Specialty Chemicals division, IOL manufactures Ethyl Acetate, Iso Butyl Benzene (IBB), Mono Chloro Acetic Acid (MCA), and Acetyl Chloride.

About Kabra Drugs Ltd

Kabra Drugs Ltd was incorporated as a Limited Company on August 22, 1989.
The Company has set up a Unit at Indore for manufacturing of Ether derivatives which includes Diethyl Ether (Anesthesia), Solvent Ether, Ethyl Chloride Spray (General Anesthesia) and Surgical.
The commercial production commenced in 1991.
Kabra Drugs Limited is the only manufacturer of Ether derivatives in the State of M.P. tHE Company is presently engaged in the business of Permaculture manufacturing and trading in pharma related products. The latest addition to the product line is the range of disinfectants which includes hand wash gel, hand sanitizer and antimicrobial gel.
In India there are very few manufacturers who are manufacturing the said products.

FAQs for the comparison of IOL Chemicals & Pharmaceuticals Ltd and Kabra Drugs Ltd

Which company has a larger market capitalization, IOL Chemicals & Pharmaceuticals Ltd or Kabra Drugs Ltd?

Market cap of IOL Chemicals & Pharmaceuticals Ltd is 2,778 Cr while Market cap of Kabra Drugs Ltd is 58 Cr

What are the key factors driving the stock performance of IOL Chemicals & Pharmaceuticals Ltd and Kabra Drugs Ltd?

The stock performance of IOL Chemicals & Pharmaceuticals Ltd and Kabra Drugs Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for IOL Chemicals & Pharmaceuticals Ltd and Kabra Drugs Ltd?

As of May 5, 2026, the IOL Chemicals & Pharmaceuticals Ltd stock price is INR ₹94.66. On the other hand, Kabra Drugs Ltd stock price is INR ₹24.51.

How do dividend payouts of IOL Chemicals & Pharmaceuticals Ltd and Kabra Drugs Ltd compare?

To compare the dividend payouts of IOL Chemicals & Pharmaceuticals Ltd and Kabra Drugs Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.